[1]
A. Yehya, J. M. Miles, and R. K. Bhattacharya, “Savella® (Milnacipran) Causing Elevated Normetanephrines”, kjm, vol. 9, no. 3, pp. 71–73, Jan. 2019, doi: 10.17161/kjm.v9i3.8618.